July 2, 2018
Philadelphia-based Carisma Therapeutics closes $53 million venture capital financing – Philadelphia Business Journal
Carisma Therapeutics, formerly Carma Therapeutics, is working on a new onco-immunotherapy approach for treating cancer…
July 2, 2018
QIAGEN announces broadening of GeneReader NGS System applications into hereditary disease analysis | Business Wire
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today introduced seamless next-generation sequencing (NGS) solutions…
